CYP cynata therapeutics limited

Ann: First Patient Treated in Phase 2 GvHD Trial, page-53

  1. 2,282 Posts.
    lightbulb Created with Sketch. 1205
    @truss20 - unless you have a specific comment from since when Kilian became CEO then I think you are probably only recalling what Ross said a long time ago. ie "the company did address this" in that sense - a long time ago Ross said 30 30 but he wasn't consistent on it afterwards.

    I think this 30 30 or 40 20 split matters a lot statistically and for recruitment potentially (40 20 may well be easier - it might be part of contract terms with recruitment sites) - but I don't think its been specifically commented on since Kilian was CEO by anyone at CYP - and I do think Ross said both and the 40 20 more recently than he said 30 30.

    If you've more information, and specifically if the company has addressed this, since Kilian became CEO , then you would have more info than me, because I don't think anyone in the company has addressed this publicly in that period, then do please confirm if you can.

    Last edited by JB1975: 22/03/24
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
15.0¢
Change
-0.010(6.25%)
Mkt cap ! $33.89M
Open High Low Value Volume
15.5¢ 16.0¢ 15.0¢ $20.57K 135.2K

Buyers (Bids)

No. Vol. Price($)
6 149482 14.5¢
 

Sellers (Offers)

Price($) Vol. No.
16.0¢ 8338 1
View Market Depth
Last trade - 14.33pm 15/07/2025 (20 minute delay) ?
CYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.